The board of directors of China Health Group Limited announced that, with effect from 11 December 2017, Mr. Zhang Fan, the executive Director, has been appointed as chairman of the company; Mr. Chung Ho, the executive Director, has been appointed as chief executive officer of the company; and Mr. Wang Jingming, the executive Director, has been appointed as hospital chief executive of the Group. The Board announced that Mr. Du Yanhua ("Mr. Du") has been appointed as an independent non-executive Director with effect from 11 December 2017. Mr. Du Yanhua has been a technical manager in the Aids Institute, LKS Facultyof Medicine in The University of Hong Kong since March 2012, a senior project manager of Immuno Cure Limited since May 2015 and the chief executive officer of Shenzhen Yike Bio-technical Limited since October 2017.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.91 HKD | 0.00% | -2.15% | -7.14% |
Jul. 09 | China Health Group to Raise Over HK$11 Million via Share Subscription | MT |
Jul. 08 | China Health Unit to Buy Molecular Diagnostics Technology Firm | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 55.83M | |
-13.97% | 8.34B | |
+14.29% | 1.45B | |
-5.71% | 1.36B | |
-28.70% | 1.05B | |
-33.75% | 695M | |
-.--% | 622M | |
+4.78% | 469M | |
+1.02% | 427M | |
-37.14% | 278M |
- Stock Market
- Equities
- 673 Stock
- News China Health Group Limited
- China Health Group Limited Announces Executive Appointments